Telge Projects (544544)
Fast GrowerScore breakdown: P/E: 2/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹93 |
| Market Cap | ₹91.05 Cr |
| P/E Ratio | 16.52 |
| ROCE | 55.4% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 277.27% |
| Debt/Equity | — |
| Sales Growth | 71.32% |
| Sector | Construction |
Strengths
- ROCE of 55.40% indicates strong capital efficiency
- Sales growth of 71.32% shows rapid business expansion
- Profit growth of 277.27% with a PEG of 0.09 suggests low valuation relative to growth
- Piotroski F-Score of 7/9 points to healthy fundamentals
- Latest quarter is profitable with ₹1 Cr net profit on ₹9 Cr sales
Concerns
- Critical balance sheet data missing: no book value, ROE, or debt/equity ratio
- Tiny market cap of ₹91 Cr makes it a high-risk microcap
- Zero dividend yield offers no income support for investors
- 277% profit growth likely off a small base and may not be sustainable in a cyclical construction business
AI Analysis
Looking at Telge Projects, I am reminded that small construction companies can be wonderful growers but dangerous investments. At ₹93, the market capitalises Telge at just ₹91 crore. That is a microcap by any standard. The trailing P/E of 16.52 is not demanding if the growth is real: sales grew 71.32% and profits jumped 277.27%. A PEG of 0.09 suggests the market is paying very little for that momentum. ROCE of 55.40% is exceptional, and the Piotroski score of 7/9 points to decent financial health. Yet I must pause. Graham taught me to demand a margin of safety. Here book value, ROE, and debt/equity are simply not available. I cannot tell how much equity backs my rupee or how leveraged the balance sheet is. The latest quarter shows sales of ₹9 crore and net profit of ₹1 crore; annualised, that is only ₹4 crore against a ₹91 crore market cap. That is not cheap unless growth continues for several years. Construction is cyclical, competitive, and working-capital heavy. A 277% profit jump often comes off a tiny base and is rarely repeatable. There is no dividend to cushion a patient investor. I would not rule out owning it, but I would demand more data: audited balance sheet, cash flow, debt position, promoter holding, and order book visibility. In a small cap, the promoter's skin in the game and the company's ability to collect cash matter as much as the income statement. Telge has the numbers of a fast grower, but the missing information prevents a Graham-style conclusion. I would wait on the sidelines until the picture is complete.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer